Skip to main content

Table 2 Adverse events based on worst grade toxicity experienced during preoperative and postoperative chemotherapy.

From: A phase II experience with neoadjuvant irinotecan (CPT-11), 5-fluorouracil (5-FU) and leucovorin (LV) for colorectal liver metastases

Adverse Event

Preoperative Chemotherapy (n = 35)

Postoperative Chemotherapy (n = 22)

 

Grade 1/2

N (%)

Grade 3/4

N (%)

Grade

1/2

N (%)

Grade 3/4

N (%)

Gastrointestinal

    

   Nausea/vomiting

25 [71]

0 (0)

17 (77)

0 (0)

   Diarrhea

19 (54)

2 (6)

11 (50)

1 (5)

   Constipation

8 (23)

1 (3)

8 (36)

0 (0)

   Anorexia

7 (20)

0 (0)

3 (14)

0 (0)

   Mucositis/stomatitis

11 (31)

0 (0)

8 (36)

0 (0)

   Small Bowel Perforation

0 (0)

1 (3)

0 (0)

0 (0)

   Other: heartburn, dyspepsia, gas pain, taste alteration, dysgeusia, hiccups, dry mouth, abdominal cramping, dysphagia

12 (34)

0 (0)

11 (50)

0 (0)

Constitutional

    

   Fatigue or lethargy or insomnia

30 (86)

0 (0)

16 (73)

0 (0)

   Diaphoresis/flushing

4 (11)

0 (0)

1 (5)

0 (0)

   Other: fever, cough, cold

3 (9)

0 (0)

1 (5)

0 (0)

Infection

10 (29)

2 (6)

5 (23)

2 (9)

Pain

7 (20)

0 (0)

7 (32)

0 (0)

Laboratory: Hematological

    

   Lymphopenia

1 (3)

2 (6)

2 (9)

0 (0)

   Neutropenia

12 (34)

4 (11)

8 (36)

9 (41)

   Anemia

13 (37)

0 (0)

9 (41)

0 (0)

   Thrombocytopenia

4 (11)

0 (0)

8 (36)

0 (0)

Laboratory: Biochemistry

    

   Elevated liver function tests: AST, ALT, bilirubin, alkaline phosphatase, LDH

6 (17)

0 (0)

5 (23)

0 (0)

   Elevated creatinine

2 (6)

0 (0)

1 (5)

0 (0)

   Decreased protein/albumin

2 (6)

0 (0)

2 (9)

0 (0)

   Coagulation abnormalities: INR/PTT

0 (0)

1 (3)

0 (0)

1 (5)

   Miscellaneous electrolyte and metabolic disturbances: hypermagnesemia, elevated phosphorous, hypocalcemia, hypokalemia

2 (6)

1 (3)

1 (5)

0 (0)

Thromboembolic

    

   Deep vein thrombosis

0 (0)

5 (14)

0 (0)

4 (18)

   Acute myocardial infarction

0 (0)

1 (3)

0 (0)

0 (0)

Dermatology/Skin

    

   Erythemia, rash, desquamation

7 (20)

0 (0)

5 (23)

0 (0)

   Alopecia

7 (20)

0 (0)

4 (18)

0 (0)

Miscellaneous: Other

    

   Blurred vision/eye irritation

6 (17)

0 (0)

4 (18)

0 (0)

   Mood alteration: agitation, anxiety, depression, hyperactivity

7 (20)

2 (6)

5 (23)

0 (0)